GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Innovative Pharmaceutical Biotech Ltd (HKSE:00399) » Definitions » Price-to-Operating-Cash-Flow

Innovative Pharmaceutical Biotech (HKSE:00399) Price-to-Operating-Cash-Flow : (As of May. 17, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Innovative Pharmaceutical Biotech Price-to-Operating-Cash-Flow?

As of today (2024-05-17), Innovative Pharmaceutical Biotech's share price is HK$0.195. Innovative Pharmaceutical Biotech's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was HK$-0.01. Hence, Innovative Pharmaceutical Biotech's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Innovative Pharmaceutical Biotech's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, Innovative Pharmaceutical Biotech's highest Price-to-Operating-Cash-Flow Ratio was 7.68. The lowest was 5.61. And the median was 5.85.

HKSE:00399's Price-to-Operating-Cash-Flow is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 10.82
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Innovative Pharmaceutical Biotech's Cash Flow from Operations per share for the six months ended in Sep. 2023 was HK$-0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was HK$-0.01.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 21.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 7.20% per year.

During the past 13 years, Innovative Pharmaceutical Biotech's highest 3-Year average Operating Cash Flow per Share Growth Rate was 40.50% per year. The lowest was -25.60% per year. And the median was 17.15% per year.


Innovative Pharmaceutical Biotech Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Innovative Pharmaceutical Biotech's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovative Pharmaceutical Biotech Price-to-Operating-Cash-Flow Chart

Innovative Pharmaceutical Biotech Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Innovative Pharmaceutical Biotech Semi-Annual Data
Dec13 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Innovative Pharmaceutical Biotech's Price-to-Operating-Cash-Flow

For the Household & Personal Products subindustry, Innovative Pharmaceutical Biotech's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innovative Pharmaceutical Biotech's Price-to-Operating-Cash-Flow Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Innovative Pharmaceutical Biotech's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Innovative Pharmaceutical Biotech's Price-to-Operating-Cash-Flow falls into.



Innovative Pharmaceutical Biotech Price-to-Operating-Cash-Flow Calculation

Innovative Pharmaceutical Biotech's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.195/-0.013
=

Innovative Pharmaceutical Biotech's Share Price of today is HK$0.195.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Innovative Pharmaceutical Biotech's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was HK$-0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Innovative Pharmaceutical Biotech Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Innovative Pharmaceutical Biotech's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Innovative Pharmaceutical Biotech (HKSE:00399) Business Description

Traded in Other Exchanges
N/A
Address
168-200 Connaught Road Central, Unit No. 2111, 21st Floor, Sheung Wan, West Tower Shun Tak Centre, Hong Kong, HKG
Innovative Pharmaceutical Biotech Ltd is focused on developing an insulin product that could be administered orally. It has two primary segments of business: the research and development of pharmaceutical products and the trading of beauty products. It generates maximum revenue from trading in the beauty products segment.

Innovative Pharmaceutical Biotech (HKSE:00399) Headlines

No Headlines